Cytolin: Began Phase I/II trial

Amerimmune Inc., Los Angeles, Calif. Product: Cytolin Business: Infectious diseases Therapeutic category: Antibody, Immune modulation Target: Adhesion molecules on immune cells Description: Monoclona...